“…The question of how rapid is rapid tends to evolve with time. It was only 20 years ago that soft lithography was widely considered to be an RP solution to microfluidic-device fabrication, and it is now considered to be the benchmark for improvement. To this end, despite the above-mentioned drawbacks, microfluidic devices can be printed in less than an hour using standard 3D-printing methods at a cost anywhere between $0.1 and $4 per chip, depending on which method is used .…”
Microfluidics has been shown to be capable of generating a range of single-and multi-compartment vesicles and bilayer delineated droplets that can be assembled in 2D and 3D. These model systems are becoming increasingly recognized as powerful biomimetic constructs for assembling tissue models, engineering therapeutic delivery systems and for screening drugs. One bottleneck in developing this technology is the time, expertise and equipment required for device fabrication. This has led to interest across the microfluidics community in using rapid prototyping to engineer microfluidic devices from Computer Aided Design (CAD) drawings. We highlight how this rapid prototyping revolution is transforming the fabrication of microfluidic devices for bottom-up synthetic biology. We provide an outline of the current landscape and present how advances in the field may give rise to the next generation of multifunctional biodevices, particularly with Industry 4.0 on the horizon. Successfully developing this technology and making it open-source could pave the way for a new generation of citizen-led science, fueling the possibility that the next multibillion dollar start-up could emerge from an attic or a basement.
“…The question of how rapid is rapid tends to evolve with time. It was only 20 years ago that soft lithography was widely considered to be an RP solution to microfluidic-device fabrication, and it is now considered to be the benchmark for improvement. To this end, despite the above-mentioned drawbacks, microfluidic devices can be printed in less than an hour using standard 3D-printing methods at a cost anywhere between $0.1 and $4 per chip, depending on which method is used .…”
Microfluidics has been shown to be capable of generating a range of single-and multi-compartment vesicles and bilayer delineated droplets that can be assembled in 2D and 3D. These model systems are becoming increasingly recognized as powerful biomimetic constructs for assembling tissue models, engineering therapeutic delivery systems and for screening drugs. One bottleneck in developing this technology is the time, expertise and equipment required for device fabrication. This has led to interest across the microfluidics community in using rapid prototyping to engineer microfluidic devices from Computer Aided Design (CAD) drawings. We highlight how this rapid prototyping revolution is transforming the fabrication of microfluidic devices for bottom-up synthetic biology. We provide an outline of the current landscape and present how advances in the field may give rise to the next generation of multifunctional biodevices, particularly with Industry 4.0 on the horizon. Successfully developing this technology and making it open-source could pave the way for a new generation of citizen-led science, fueling the possibility that the next multibillion dollar start-up could emerge from an attic or a basement.
“…Microfluidic techniques provide an ideal tool for in situ manipulation of biological cells. However, the well-established microfluidic devices based on soft lithography [131,132], which are often used in combination with optical microscopy and are fabricated of polymers like polydimethylsiloxane (PDMS), bring about the problem of showing a high X-ray absorption and a strong background signal in the small-angle region [133]. A variety of X-ray compatible microfluidic devices based on different materials and fabrication techniques has been proposed in the past as reviewed by Köster and Pfohl [38].…”
Section: Sample Environments For Hydrated Cellsmentioning
“…Controlling the layer formation of nanomaterials on a substrate is a crucial aspect for their application in most electronic devices . The Huisgen -1,3-dipolar cycloaddition, also referred to as copper-catalyzed alkyneâazide cycloaddition (CuAAC) reaction in case of a Cu + catalyst, has been introduced by Sharpless and Meldal in 2001 and quickly became known as the prototypic Click reaction due to its simplicity. â The CuAAC reaction also shows rather remarkable substrate tolerance, and it has been quickly applied to the field of materials and surface chemistry. â For example, it has been demonstrated that the CuAAC reaction can be used to direct layered deposition of coreâshell functionalized nanoparticles (NPs) that bear either an alkyne or an azide headgroup in their organic ligand shell, and accordingly functionalized self-assembled monolayer (SAM) substrates. â Recently, we reported on a method in which three different layers of coreâshell NPs could be hierarchically assembled using a layer-by-layer process, controlled by the CuAAC .…”
We demonstrate that the dispersibility and reactivity of core-shell TiO nanorods (NRs) can be controlled significantly through functionalization with a combination of ligands based on phosphonic acid derivatives (PAs). Specifically, a glycol based PA allows dispersion of the NRs in methanol (MeOH). On the other hand, incorporating an alkyne terminated PA in the ligand shell of the NRs allows for a copper-catalyzed alkyne-azide cycloaddition (CuAAC) reaction with an azide-patterned aluminum oxide (AlO) substrate and forms a region-selectively deposited film of NRs. We clearly demonstrate that the quality of the NR films correlates strongly with the stability of the NR dispersions in the reaction medium. In particular, tuning the concentration of alkyne PA in the ligand shell inhibits aggregation of the NRs on the substrate, while reactivity for the CuAAC reaction is maintained. The surface coverage with NRs fits the Langmuir model. This study illustrates that surface functionalization of AlO substrates can be effectively and conveniently controlled through enhancing the dispersibility of the NRs using mixed ligand shells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.